Video Experimental Relacionado
Updated: Jun 21, 2026

06:56
Isolation of Double Negative αβ T Cells from the Kidney
Published on: May 16, 2014
Una mutación sin sentido en el gen Cd36 se asocia con la protección contra la malaria severa
Lancet (London, England)
|May 30, 2001
Resumen
Una mutación del gen CD36 ofrece protección contra la malaria severa en niños africanos. Este hallazgo genético pone de relieve las complejas interacciones huésped-parásito en los resultados de la malaria.
Área de la Ciencia:
- Genética La genética.
- Inmunología Inmunología.
- Enfermedades infecciosas Enfermedades infecciosas.
Sus antecedentes:
- Investigar el papel de los factores genéticos del huésped en la patogénesis de la malaria.
- Centrándose en las interacciones huésped-parásito que involucran CD36 en la malaria severa.
- Examinando una mutación absurda específica dentro del gen CD36.
Más Videos Relacionados
Videos de Conceptos Relacionados
Mismatch Repair
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...

